Try it
OBG · Menopause: hormone therapy
Sample itemFor a patient with an intact uterus receiving systemic estrogen therapy for menopausal vasomotor symptoms, what additional hormone is generally required to protect the endometrium?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
B. A progestogen
Unopposed systemic estrogen can stimulate the endometrium and increase hyperplasia and cancer risk in people with a uterus. Adding an adequate progestogen provides endometrial protection.
Option by option
A. Testosterone only
Testosterone does not provide standard endometrial protection.
B. A progestogen (correct)
Correct. Progestogen opposes estrogenic endometrial proliferation.
C. Human chorionic gonadotropin
hCG is a pregnancy hormone, not menopausal therapy.
D. Oxytocin
Oxytocin contracts the uterus and has no role in menopausal endometrial protection.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More OBG questions
- Menopause: hormone therapyA 52-year-old woman with an intact uterus has severe vasomotor symptoms. Which hormone t…
- Antenatal careA woman's last menstrual period began on 10 January 2026. Using Naegele's rule, what is…
- Obstetric drugsCarboprost (15-methyl PGF2α) is contraindicated in which condition?
- Hypertensive disorders of pregnancyA primigravida at 34 weeks has a blood pressure of 150/100 mmHg on two occasions and 2+…